We’re proud to be leading the field in #RNAediting including applications across cell and tissue types. At this week’s meeting of the Oligonucleotide Therapeutics Society, Wave’s VP of Research Pharmacology Michael Byrne highlighted our editing work in the CNS. Thanks to all who joined the presentation!
What a great week! Had a wonderful time seeing friends and meeting new ones at this year’s Oligo Therapeutics Society meeting #OTS24 in Montreal! Thank you for the opportunity to share Wave’s progress in advancing our AIMers for ADAR editing in the central nervous system.